Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Procter & Gamble CoWAR:PCGL 72 3-Year EPS without NRI Growth Rate is 5.30% as of Jun. 2026, which is 38% below its 10-year median of 8.50. GuruFocus rates WAR:PCGL with a GF Score™ of 72/100 and a GF Value™ of zł648.74 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 1,533 Consumer Packaged Goods companies, Procter & Gamble Co ranks worse than 52.97% on this metric.
During the past 12 months, Procter & Gamble Co's average EPS without NRI Growth Rate was 0.90% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 5.30% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 4.60% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 6.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Procter & Gamble Co was 69.90% per year. The lowest was -8.10% per year. And the median was 8.50% per year.
Procter & Gamble Co (WAR:PCGL) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Procter & Gamble Co 3-Year EPS without NRI Growth Rate Related Terms
WAR:PCGL vs CL, EL, KVUE: 3-Year EPS without NRI Growth Rate Comparison
For the Household & Personal Products subindustry, Procter & Gamble Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Procter & Gamble Co 3-Year EPS without NRI Growth Rate vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Procter & Gamble Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Procter & Gamble Co's 3-Year EPS without NRI Growth Rate falls into.
Procter & Gamble Co 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 5.30% mean?
Procter & Gamble Co (WAR:PCGL) has a 3-Year EPS without NRI Growth Rate of 5.30% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Procter & Gamble Co and its competitors. This is 38% below median its historical median of 8.50. According to the industry distribution chart, Procter & Gamble Co ranks #812 out of 1533 companies in the Consumer Packaged Goods industry, placing it in the top 53%.
Is Procter & Gamble Co's 3-Year EPS without NRI Growth Rate too high?
Procter & Gamble Co's current 3-Year EPS without NRI Growth Rate of 5.30% is 38% below median its 10-year median of 8.50. The Consumer Packaged Goods industry median 3-Year EPS without NRI Growth Rate is 7.20. Procter & Gamble Co's value of 5.30% is 26.4% below this industry median. Based on the distribution chart, Procter & Gamble Co ranks #812 out of 1533 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Procter & Gamble Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Co's 3-Year EPS without NRI Growth Rate compare to CL and EL?
According to the Consumer Packaged Goods industry distribution chart, Procter & Gamble Co ranks #812 out of 1533 companies for 3-Year EPS without NRI Growth Rate. This places Procter & Gamble Co in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 7.20. Procter & Gamble Co's value of 5.30% is 26.4% below this benchmark. While the company's 10-year median is 8.50 vs. the industry median of 7.20, Procter & Gamble Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EPS without NRI Growth Rate among Consumer Packaged Goods companies is 7.20, based on 1,533 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Procter & Gamble Co's current 3-Year EPS without NRI Growth Rate of 5.30% is 26.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Procter & Gamble Co and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EPS without NRI Growth Rate is 7.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Procter & Gamble Co's current 3-Year EPS without NRI Growth Rate is 5.30%, which is 38% below median its own 10-year median of 8.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Co stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Co (WAR:PCGL) is currently considered Modestly Undervalued. The stock's GF Value™ is zł648.74, compared to a current price of zł544.30 — trading 16.1% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 5.30%, which is 38% below median its 10-year median of 8.50 and 26.4% below the Consumer Packaged Goods industry median of 7.20. Procter & Gamble Co's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Procter & Gamble Co (WAR:PCGL), the current 3-Year EPS without NRI Growth Rate is 5.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Procter & Gamble Co (WAR:PCGL) Overvalued in 2026?
Based on GuruFocus' analysis, Procter & Gamble Co stock appears to be undervalued.
The current stock price of zł544.30 is trading 16.1% below its estimated GF Value™ of zł648.74.
GuruFocus considers Procter & Gamble Co to be Modestly Undervalued.
Key valuation signals for WAR:PCGL:
3-Year EPS without NRI Growth Rate: 5.30% (38% below median its 10-year median of 8.50)
GF Value™: zł648.74 vs. price of zł544.30 (16.1% below fair value)
Industry Position: 26.4% below the Consumer Packaged Goods median (#812 of 1533)
No single metric tells the full story. See the WAR:PCGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.
72GF Score
Get the complete analysis for WAR:PCGL
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PCGL has been successfully added to your 
